Shares of Cigna Corporation (NYSE:CI) have earned an average recommendation of “Buy” from the eighteen brokerages that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $201.50.
A number of analysts recently commented on CI shares. Deutsche Bank AG upped their price objective on Cigna Corporation from $180.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, August 7th. Credit Suisse Group reiterated a “buy” rating and set a $196.00 price objective on shares of Cigna Corporation in a research report on Friday, August 4th. Jefferies Group LLC reiterated a “buy” rating and set a $190.00 price objective (down previously from $199.00) on shares of Cigna Corporation in a research report on Friday, August 4th. BidaskClub cut Cigna Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $175.00 price objective on shares of Cigna Corporation in a research report on Friday, July 28th.
Cigna Corporation (NYSE CI) traded up $3.51 during trading on Friday, reaching $201.90. The company had a trading volume of 1,238,151 shares, compared to its average volume of 1,508,257. The company has a market cap of $49,778.45, a PE ratio of 19.45, a PEG ratio of 1.49 and a beta of 0.49. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.40 and a quick ratio of 0.40.
Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. The company had revenue of $10.38 billion during the quarter, compared to analysts’ expectations of $10.17 billion. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. Cigna Corporation’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.94 earnings per share. equities analysts predict that Cigna Corporation will post 10.39 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Cigna Corporation (CI) Receives Average Recommendation of “Buy” from Analysts” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.com-unik.info/2017/11/05/cigna-corporation-ci-receives-average-recommendation-of-buy-from-analysts.html.
In related news, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $185.27, for a total transaction of $45,761.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jason D. Sadler sold 37,756 shares of the stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $176.16, for a total value of $6,651,096.96. Following the sale, the insider now owns 47,844 shares of the company’s stock, valued at approximately $8,428,199.04. The disclosure for this sale can be found here. Insiders have sold 45,696 shares of company stock valued at $8,070,481 in the last quarter. 1.30% of the stock is currently owned by company insiders.
Large investors have recently added to or reduced their stakes in the stock. American Beacon Advisors Inc. bought a new position in Cigna Corporation during the first quarter valued at approximately $102,000. Capstone Investment Advisors Netherlands B.V. bought a new position in Cigna Corporation during the second quarter valued at approximately $106,000. Saratoga Research & Investment Management bought a new position in Cigna Corporation during the third quarter valued at approximately $112,000. Parallel Advisors LLC boosted its stake in Cigna Corporation by 62.3% during the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after buying an additional 307 shares during the last quarter. Finally, Acrospire Investment Management LLC boosted its stake in Cigna Corporation by 66.7% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock valued at $167,000 after buying an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 88.23% of the company’s stock.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
What are top analysts saying about Cigna Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cigna Corporation and related companies.